1 / 9

Rob Jelier

Commonalties of, and differences between hormonal pathways in breast, endometrium, and prostate cancer. Rob Jelier. What could I contribute? . Experts:. Guido Jenster Urology Prostate Cancer. Lambert Dorssers Pathology Breast Cancer. Leen Blok Gynecology Endometrial Cancer.

luke
Download Presentation

Rob Jelier

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Commonalties of, and differences between hormonal pathways in breast, endometrium, and prostate cancer Rob Jelier

  2. What could I contribute? Experts: Guido Jenster Urology Prostate Cancer Lambert Dorssers Pathology Breast Cancer Leen Blok Gynecology Endometrial Cancer

  3. DNA Microarray Datasets • PRIMA dataset: Gene expression measured following stimulation of the AR by the synthetic androgen R1881 in the prostate cancer cell line LNCaP. • Best dataset: Gene expression profiles of 10 androgen-independent primary prostate tumor biopsies and 10 primary, untreated androgen-dependent tumors. • Frasor dataset: Gene expression measured following stimulation of the ER by estradioll in the breast cancer cell line MCF7. Also data on the selective estrogen receptor modulators Tamoxifen, Raloxifene or ICI 182,780 alone and the latter three in combination with estradiol.

  4. DNA Microarray Datasets • Blok cell line dataset: Gene expression measured following stimulation of the PGR and the ER in the endometrial cancer cell line MCF7 in a time series. The cells were subjected to: • estradiol • estradiol and MPA (an progesterone derivate) • MPA • tibolone • Blok Patient Material Dataset: 30 healthy post-menopausal women were subjected to hormone treatments prior to hysterectomy for endometrial prolaps. The hormone treatments were: 1. estradiol; 2. estradiol + progestagen; 3. tibolone.

  5. DNA Micro-arrays Lots of Data Background information is desirable e.g. urology: 18K gene expression profiles for a series of hybridizations. For one experiment >100 potentially relevant genes • Gene Function • Part of regulatory pathway • Tissue/cell type specific expression • Protein localization • Chromosomal gene location • Role in cancer • Known co-expressed genes

  6. Concept Profiling, what it does • GABARAPL2 • BNIP2 • ARHGAP8 • RAP1GA1 • GMIP • CDC42EP4 • ITSN1 • BCL11B • CD1E • IL7R • GNLY • GZMK • GZMH • GZMB • PRF1 • GZMA • IL2RB • UCHL1 • KLRK1 • KLRD1 • KLRB1 • TNFRSF7 • CD6 • CD2 • CD8A

  7. Concept Profile: ESR1 estrogen receptor 1 breast neoplasm 0.5 BRCA1 0.34 PGR 0.30 Estrogen 0.28 BRCA2 0.25 TP53 0.15 gene suppressor tumor 0.12 genetics polymorphism 0.12 genetic predisposition to disease 0.10 female 0.05

  8. Anni • www.biosemantics.org/anni

  9. Other contributions • Information retrieval • e.g. Give me all the genes associated with Androgen Receptor

More Related